[Occult cancer in patients with symptomatic benign prostatic hyperplasia].
The results of a prospective study undertaken in 29 patients with symptomatic benign prostatic hyperplasia (BPH) are presented. Transrectal ultrasound, ultrasound-guided biopsy and prostate specific antigen (PSA) were utilized in the search for hidden cancer of the prostate. However, no cancer was detected in any patient. Very high values of PSA were found, particularly in patients with an indwelling catheter. Transrectal ultrasound yielded no false negatives and no complications were observed.
Rodríguez Duarte
C
C
Centro de Ultrasonido Prostático, Policlínica Metropolitana, Caracas, Venezuela.
Aguillón
J
J
Rodríguez
H
H
D000230:Adenocarcinoma / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D000368:Aged; D000369:Aged, 80 and over; D000951:Antigens, Neoplasm / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D017430:Prostate-Specific Antigen; D011470:Prostatic Hyperplasia / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D011471:Prostatic Neoplasms / Q000097:blood / Q000150:complications / Q000175:diagnosis*
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen
Investigacón de cáncer oculto en pacientes con hiperplasia prostática benigna sintomática.